Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Severe sepsis, coagulation, and fibrinolysis: dead end or one way?

Fourrier F.

Crit Care Med. 2012 Sep;40(9):2704-8. doi: 10.1097/CCM.0b013e318258ff30. Review.

PMID:
22732284
2.

The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis.

Zarychanski R, Abou-Setta AM, Kanji S, Turgeon AF, Kumar A, Houston DS, Rimmer E, Houston BL, McIntyre L, Fox-Robichaud AE, H├ębert P, Cook DJ, Fergusson DA; Canadian Critical Care Trials Group.

Crit Care Med. 2015 Mar;43(3):511-8. doi: 10.1097/CCM.0000000000000763. Review.

PMID:
25493972
3.

[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] .

Baudo F, de Cataldo F.

Minerva Anestesiol. 2000 Nov;66(11 Suppl 1):3-23. Review. Italian.

PMID:
11213542
4.
5.

Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials.

Umemura Y, Yamakawa K, Ogura H, Yuhara H, Fujimi S.

J Thromb Haemost. 2016 Mar;14(3):518-30. doi: 10.1111/jth.13230. Epub 2016 Feb 1. Review.

6.

Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation.

Levi M, de Jonge E, van der Poll T.

Crit Care Med. 2001 Jul;29(7 Suppl):S90-4. Review.

PMID:
11445740
7.
8.

Clinical impact of novel anticoagulation strategies in sepsis.

Opal SM.

Curr Opin Crit Care. 2001 Oct;7(5):347-53. Review.

PMID:
11805532
9.

Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation.

Esmon CT.

Crit Care Med. 2001 Jul;29(7 Suppl):S48-51; discussion 51-2. Review.

PMID:
11445734
10.

Reducing mortality in severe sepsis and septic shock.

Levinson AT, Casserly BP, Levy MM.

Semin Respir Crit Care Med. 2011 Apr;32(2):195-205. doi: 10.1055/s-0031-1275532. Epub 2011 Apr 19. Review.

PMID:
21506056
11.

Coagulation in severe sepsis: a central role for thrombomodulin and activated protein C.

Faust SN, Heyderman RS, Levin M.

Crit Care Med. 2001 Jul;29(7 Suppl):S62-7; discussion S67-8. Review.

PMID:
11445736
12.

A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis.

Wiedermann CJ, Kaneider NC.

Blood Coagul Fibrinolysis. 2006 Oct;17(7):521-6. Review.

PMID:
16988545
13.

The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation.

Iba T, Nagaoka I, Boulat M.

Thromb Res. 2013 May;131(5):383-9. doi: 10.1016/j.thromres.2013.03.012. Epub 2013 Apr 6. Review.

PMID:
23566533
14.

[Adjuvant therapies for sepsis and shock: which are more effective?].

Groeneveld AB, Beishuizen A, Appelmelk BJ, Girbes AR.

Ned Tijdschr Geneeskd. 2001 Sep 8;145(36):1718-22. Review. Dutch.

PMID:
11572169
15.

The coagulation cascade in sepsis.

Wang L, Bastarache JA, Ware LB.

Curr Pharm Des. 2008;14(19):1860-9. Review.

PMID:
18691097
16.

[Activated protein C].

Uchiba M.

Rinsho Byori. 2011 Feb;Suppl 147:171-6. Review. Japanese. No abstract available.

PMID:
21761767
17.

Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis.

Yamakawa K, Aihara M, Ogura H, Yuhara H, Hamasaki T, Shimazu T.

J Thromb Haemost. 2015 Apr;13(4):508-19. doi: 10.1111/jth.12841. Epub 2015 Mar 5. Review. Erratum in: J Thromb Haemost. 2015 Jul;13(7):1358-9.

18.

Lack of evidence for qualitative treatment by disease severity interactions in clinical studies of severe sepsis.

Macias WL, Nelson DR, Williams M, Garg R, Janes J, Sashegyi A.

Crit Care. 2005;9(6):R607-22. Epub 2005 Sep 22. Review.

19.

The current management of septic shock.

Russel JA.

Minerva Med. 2008 Oct;99(5):431-58. Review.

PMID:
18971911
20.

Disseminated intravascular coagulation in sepsis.

Zeerleder S, Hack CE, Wuillemin WA.

Chest. 2005 Oct;128(4):2864-75. Review.

PMID:
16236964

Supplemental Content

Support Center